An Eighteen-Month-Two-Arm, Reandomized, Double-Masked-Multi-center, Phase iii Study Assessing the Efficacy and Safety of Brolucizumab versus Aflibercept in Adult Patients with Visual Imapirment due to Macular Edema secondary to Branch Retinal Vein Occlusion (RAPTOR)
Forschungs-